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I-123 me&aiodobenzylguanidine(MIBG) is a new ra 
ceutical agent that reflects sympathetic nerve f 
tXtIt myocardfal infaretion(AMI), greater defects are 
observed with MIBG than with Tl-201(Tl).In this study, 
simultaneous MIBG/Tl myocardial SPECT(M-S) was performed 
in 20 AM1 patient(pts) to compare with exercise myocardi- 
al SPECT(EX-S) and simultaneous 99m-Tc-PYP/Tl myocardial 
SPECT(PYP-S).M-S was feasible during acute(within 2 weeks 
of dLsease onset), subacute(within 2 months of onset) and 
chronic(2 months after onset or later) stages in 16, 15 
and 11 ptsr respectively. Por each ease, 20 segments of 
SPECT image were visually scored and a defect score(DS) 
was assigned. DS was greater with MIBG than with Tl, with 
respective mean Tl vs. MlBG DS being 17.7214.7 vs. 32.12 
17.9 in acute stage, 12.0$8.9 vs. 27.6+_30.6 in subacute 
stage and 11.2214.7 vs. 28.7215.2 in chronic stage(p6 
0.01). In 9 pts where a follow-up study was done, the mean 
MIBG DS was 3s.el4.9 vs. 30.1+11.7 vs. 25.9212.4 in each 
stage(the value for chronic stage was significantly 
smaller than that for acute stage, pcO.OS),In 17 cases in 
which DS was definitely greater with MIBG than with Tl(Tl/ 
MIBG ratio of DS 0.75)all showed EX-S evidence of lschemia 
In the AMI-affected area except for 3 pts with recanaliza- 
tion of infarct-related artery. Of these 17 ptsp PYP-S was 
performed in 10 pts and overlapping of Tc and Tl was noted 
in 9 pts. The denervated but viable myocardium after AM1 
was likely to be reinnervated during chronic stage. The 
dissociation of distribution between Tl and MIBG offered 
valuable information for formulating therapeutic policy. 
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We investigated myocardial blood flow ( 
transplanted (TX), denervated heart using dipyridamole 
(D)-induced vasodilatation. MBF was measured in 10 
nonrejecting TX pts with no angiographic evidence of 
coronary sclerosis 13-72 months after TX using 150-H20 
for PET dynamic imaging. Seven normal (K) volunteers 
served as a control group. Regional blBF was measured at 
rest (RI and after D infusion. ECG and BP were 
monitored to obtain double-product (DP). MBF values 
were obtained by fitting ??yocardial and arterial time 
activity curves to a 2 compartment tracer kinetic model. 
This method has been validated against gamma labelled 
microspheres in a dog model (r=0.97). Results are 
expressed in ml/g/min for MBF. 
R-MBF R-DP D-WBF D-DP 
TX 1.0210.20 11437+2881 1.98rO.48 1180242525 
N 0.79fD. 11 714621628 2.95i0.83 1053211692 
p (t-test) 0.011 0.0016 0.008 0.238 
The higher R-MBF observed in TX pts was proportionalLy 
related to a higher R-DP. There was no Significant 
increase (4%) In DP in TX pts and a 47% increase in N to 
D infusion. MBF increased 2 times the control VdW?S in 
TX pts. It is concluded that Tx pta have a higher 
resting MBF and a preserved vasodilatory response tQ 
dipyridamole, however smaller than that observed in 
N subjects. 
